Loudon Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Hold |
485
| – | – | 0.12% | 97 |
|
|
2025
Q1 | $235K | Buy |
+485
| New | +$235K | 0.13% | 90 |
|
|
2024
Q4 | – | Sell |
-485
| Closed | -$226K | – | 101 |
|
|
2024
Q3 | $226K | Hold |
485
| – | – | 0.12% | 95 |
|
|
2024
Q2 | $227K | Hold |
485
| – | – | 0.13% | 95 |
|
|
2024
Q1 | $203K | Buy |
+485
| New | +$203K | 0.12% | 95 |
|
|
2023
Q1 | – | Sell |
-695
| Closed | -$201K | – | 93 |
|
|
2022
Q4 | $201K | Sell |
695
-340
| -33% | -$98.2K | 0.14% | 89 |
|
|
2022
Q3 | $300K | Sell |
1,035
-1,165
| -53% | -$338K | 0.24% | 76 |
|
|
2022
Q2 | $620K | Buy |
2,200
+20
| +0.9% | +$5.64K | 0.46% | 58 |
|
|
2022
Q1 | $569K | Buy |
2,180
+675
| +45% | +$176K | 0.37% | 61 |
|
|
2021
Q4 | $330K | Buy |
+1,505
| New | +$330K | 0.21% | 78 |
|